Ribosomal Protein rpL40 Modulation for Skin Elasticity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments lack the ability to effectively increase production of elastin and elastic fibers in skin cells, leading to issues with skin elasticity, texture, and wound-healing capabilities, particularly in aging and damaged skin.
Innovation Solution
A method is developed to identify and utilize compounds that modulate the rpL40-dependent translation of tropoelastin mRNA in mammalian cells, using a screening system to find cosmetically and pharmaceutically active compounds that bind to ribosomal protein rpL40, thereby enhancing tropoelastin production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current treatments are used, then skin structure is maintained, but elastin production cannot be effectively increased
Solution Approach 1:
The patent changes the molecular parameter of ribosomal protein rpL40 interaction to selectively modulate tropoelastin translation. By identifying compounds that specifically bind to rpL40 and enhance its interaction with tropoelastin mRNA, the treatment achieves increased elastin production through a novel molecular mechanism not accessible by conventional therapies.
Solution Approach 2:
The patent introduces small molecule compounds as intermediaries that mediate between the ribosomal protein rpL40 and tropoelastin mRNA. These compounds act as molecular bridges that enhance the specificity and efficiency of translation, enabling targeted increase of elastin production without affecting other proteins.
2Reliability
If conventional cosmetic treatments are applied, then skin appearance is maintained, but wound-healing capabilities deteriorate with aging
Solution Approach 1:
The patent applies preliminary action by enhancing tropoelastin production before wound healing is needed. By continuously increasing elastin synthesis through rpL40 modulation, the skin maintains better structural integrity and elasticity over time, creating a reservoir of elastic fibers that support future wound healing and prevent age-related deterioration.
3Strength
If elastin production is increased, then skin elasticity improves, but treatment complexity increases
Solution Approach 1:
The patent extracts the specific function of rpL40 in tropoelastin translation from the complex ribosomal system. By identifying and targeting this single ribosomal protein with specific small molecule compounds, the treatment isolates the critical control point for elastin production, simplifying the therapeutic approach while achieving selective enhancement of skin elasticity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively increases tropoelastin production, improving skin elasticity, texture, and wound-healing capabilities, addressing the deficiencies in existing treatments by targeting the ribosomal protein rpL40 to customize protein expression.
Implementation Method 1
modulates the rpL40-dependent translation of at least one mRNA encoding for tropoelastin in a mammalian cell
Implementation Method 2
compounds that bind to ribosomal protein rpL40
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a method for identifying a pharmaceutically or cosmetically active compound that modulates the rpL40-dependent translation of at least one mRNA encoding for tropoelastin in a mammalian cell. Furthermore, a respective screening system, methods of treating or preventing a disease or condition, and compounds as identified that modulate the rpL40-dependent translation as well synergistic combinations thereof are provided. In a preferred aspect, the cosmetically active compound is used in anti-aging products and strategies.